CIK: 0001856083 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 13, 2026
Total Value ($000): $5,608,748 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SERIES TRUST | 10,000,000 | $1,219,300 | 21.7% | — | — | PUT | 78464A870 |
| VERA | VERA THERAPEUTICS INC | 2,821,135 | $142,862 | 2.5% | $35.52 | 0.0% | CL A | 92337R101 |
| GRAL | GRAIL INC | 1,022,797 | $87,541 | 1.6% | $86.40 | 0.0% | COM | 384747101 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 4,610,071 | $60,761 | 1.1% | $11.80 | 0.0% | CLASS A ORD | 61559X104 |
| ALKS | ALKERMES PLC | 2,000,000 | $55,960 | 1.0% | $29.95 | 0.0% | SHS | G01767105 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 2,000,000 | $50,020 | 0.9% | $25.01 | — | SPONSORED ADS | 152309100 |
| SLNO | SOLENO THERAPEUTICS INC | 1,000,000 | $46,300 | 0.8% | $54.83 | 0.0% | COM | 834203309 |
| VSTM | VERASTEM INC | 5,740,850 | $44,319 | 0.8% | $8.91 | 0.0% | COM NEW | 92337C203 |
| ENTA | ENANTA PHARMACEUTICALS INC | 1,956,867 | $30,860 | 0.6% | $12.70 | 0.0% | COM | 29251M106 |
| — | ATAI BECKLEY NV | 4,677,289 | $19,130 | 0.3% | $4.09 | — | SHS | N0731H103 |
| COGT | COGENT BIOSCIENCES INC | 453,102 | $16,094 | 0.3% | $28.11 | 0.0% | COM | 19240Q201 |
| MNPR | MONOPAR THERAPEUTICS INC | 95,408 | $6,230 | 0.1% | $81.71 | 0.0% | COM NEW | 61023L207 |
| BHVN | BIOHAVEN LTD | 500,000 | $5,645 | 0.1% | — | — | CALL | G1110E107 |
| BLLN | BILLIONTOONE INC | 50,000 | $4,092 | 0.1% | $101.40 | 0.0% | CL A | 090168105 |
| IVA | INVENTIVA SA | 490,000 | $2,279 | 0.0% | $4.65 | — | ADS | 46124U107 |
| JANX | JANUX THERAPEUTICS INC | 89,589 | $1,236 | 0.0% | $23.52 | 0.0% | COM | 47103J105 |
| ANL | ADLAI NORTYE LTD | 34,852 | $49 | 0.0% | $1.42 | — | SPONSORED ADS | 00704R109 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IMVT | IMMUNOVANT INC | 11,526,971 (+18.5%) | $293,016 (+86.8%) | 5.2% | $24.15 | -7.7% | COM | 45258J102 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 2,300,000 (+9153.3%) | $136,689 (+10053.7%) | 2.4% | $54.47 | -0.1% | COM | 09061G101 |
| AXSM | AXSOME THERAPEUTICS INC | 1,150,000 (+27.8%) | $210,036 (+92.2%) | 3.7% | $113.80 | +22.7% | COM | 05464T104 |
| NRIX | NURIX THERAPEUTICS INC | 7,036,455 (+16.2%) | $133,482 (+138.5%) | 2.4% | $14.02 | +2.5% | COM | 67080M103 |
| PCVX | VAXCYTE INC | 4,000,000 (+33.3%) | $184,560 (+70.8%) | 3.3% | $44.69 | +0.1% | COM | 92243G108 |
| MAZE | MAZE THERAPEUTICS INC | 4,246,440 (+7.5%) | $175,930 (+71.8%) | 3.1% | $13.34 | +157.6% | COM | 578784100 |
| CRMD | CORMEDIX INC | 5,274,076 (+954.8%) | $61,338 (+954.8%) | 1.1% | $11.15 | -0.9% | COM | 21900C308 |
| MBX | MBX BIOSCIENCES INC | 3,249,790 (+3.2%) | $102,498 (+85.9%) | 1.8% | $20.10 | +20.7% | COM | 55287L101 |
| DYN | DYNE THERAPEUTICS INC | 2,650,000 (+32.5%) | $51,834 (+104.9%) | 0.9% | $13.25 | +42.9% | COM | 26818M108 |
| ENGN | ENGENE HOLDINGS INC | 4,377,572 (+95.5%) | $39,529 (+158.5%) | 0.7% | $9.00 | -11.0% | COM | 29286M105 |
| XFOR | X4 PHARMACEUTICALS INC | 5,013,661 (+346.7%) | $20,055 (+422.4%) | 0.4% | $3.40 | +6.9% | COM NEW | 98420X202 |
| TNGX | TANGO THERAPEUTICS INC | 2,454,562 (+68.7%) | $21,747 (+78.0%) | 0.4% | $7.52 | +14.6% | COM | 87583X109 |
| HELP | CYBIN INC | 1,854,255 (+85.4%) | $15,168 (+157.5%) | 0.3% | $8.30 | -22.5% | COM NEW | 23256X407 |
| BCAX | BICARA THERAPEUTICS INC | 2,614,004 (+7.7%) | $43,994 (+14.8%) | 0.8% | $20.52 | -16.8% | COM | 055477103 |
| — | MIND MEDICINE MINDMED INC | 1,676,540 (+11.8%) | $22,449 (+26.9%) | 0.4% | $9.37 | — | COM NEW | 60255C885 |
| IMCR | IMMUNOCORE HLDGS PLC | 2,003,978 (+11.3%) | $69,558 (+6.4%) | 1.2% | $30.47 | — | ADS | 45258D105 |
| ANIP | ANI PHARMACEUTICALS INC | 477,684 (+6.2%) | $37,708 (-8.5%) | 0.7% | $55.60 | +55.7% | COM | 00182C103 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | AKERO THERAPEUTICS INC | 4,000,978 | $189,966 | 3.4% | $37.83 | — | — | 00973Y108 |
| — | 89BIO INC | 9,356,171 | $137,536 | 2.5% | $7.72 | — | — | 282559103 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 1,715,691 | $113,973 | 2.0% | $42.89 | +90.8% | — | 74366E102 |
| EXAS | EXACT SCIENCES CORP | 1,000,000 | $54,710 | 1.0% | $49.96 | +60.7% | — | 30063P105 |
| OLMA | OLEMA PHARMACEUTICALS INC | 3,470,172 | $33,973 | 0.6% | $11.20 | +58.9% | — | 68062P106 |
| — | CIDARA THERAPEUTICS INC | 300,000 | $28,728 | 0.5% | $56.55 | — | — | 171757206 |
| QURE | UNIQURE NV | 483,092 | $28,198 | 0.5% | $18.16 | +112.5% | — | N90064101 |
| JBIO | JADE BIOSCIENCES INC | 2,279,892 | $19,675 | 0.4% | $33.31 | -64.8% | — | 008064206 |
| GHRS | GH RESEARCH PLC | 1,250,000 | $17,875 | 0.3% | $11.18 | +21.8% | — | G3855L106 |
| GMAB | GENMAB A/S | 481,267 | $14,760 | 0.3% | $30.67 | — | — | 372303206 |
| IMA | IMAGENEBIO INC | 878,516 | $7,160 | 0.1% | $13.25 | -44.1% | — | 45175G207 |
| XNCR | XENCOR INC | 549,439 | $6,445 | 0.1% | $18.57 | -19.5% | — | 98401F105 |
| PEPG | PEPGEN INC | 1,200,000 | $5,544 | 0.1% | $1.61 | +222.0% | — | 713317105 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 2,568,613 | $4,187 | 0.1% | $2.62 | — | — | 05280R100 |
| ACAD | ACADIA PHARMACEUTICALS INC | 105,085 | $2,243 | 0.0% | $23.65 | +1.0% | — | 004225108 |
| AVTX | AVALO THERAPEUTICS INC | 144,600 | $1,838 | 0.0% | $10.31 | +63.7% | — | 05338F306 |
| ZURA | ZURA BIO LTD | 259,014 | $1,122 | 0.0% | $7.12 | -44.4% | — | G9TY5A101 |
| CLYM | CLIMB BIO INC | 509,789 | $1,025 | 0.0% | $6.66 | -63.9% | — | 28658R106 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GPCR | STRUCTURE THERAPEUTICS INC | 4,111,782 (-2.5%) | $285,974 (+142.3%) | 5.1% | $26.36 | — | SPONSORED ADS | 86366E106 |
| IONS | IONIS PHARMACEUTICALS INC | 1,700,000 (-55.4%) | $134,487 (-46.0%) | 2.4% | $36.01 | +109.1% | COM | 462222100 |
| OCUL | OCULAR THERAPEUTIX INC | 8,070,414 (-32.4%) | $97,975 (-29.8%) | 1.7% | $4.46 | +172.4% | COM | 67576A100 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2,524,833 (-53.1%) | $78,573 (-32.3%) | 1.4% | $18.23 | +50.4% | COM | 92790C104 |
| XENE | XENON PHARMACEUTICALS INC | 366,435 (-69.5%) | $16,424 (-65.9%) | 0.3% | $37.01 | +13.5% | COM | 98420N105 |
| GH | GUARDANT HEALTH INC | 2,800,000 (-32.6%) | $285,992 (+10.2%) | 5.1% | $29.38 | +204.5% | COM | 40131M109 |
| TERN | TERNS PHARMACEUTICALS INC | 769,048 (-89.7%) | $31,070 (-44.8%) | 0.6% | $6.22 | +271.6% | COM | 880881107 |
| CYTK | CYTOKINETICS INC | 3,336,998 (-22.4%) | $212,033 (-10.3%) | 3.8% | $47.92 | +29.8% | COM NEW | 23282W605 |
| RAPT | RAPT THERAPEUTICS INC | 110,448 (-85.3%) | $3,741 (-80.7%) | 0.1% | $7.63 | +307.1% | COM NEW | 75382E208 |
| ORKA | ORUKA THERAPEUTICS INC | 2,161,510 (-18.6%) | $65,515 (+28.3%) | 1.2% | $19.06 | +46.2% | COM | 687604108 |
| APLS | APELLIS PHARMACEUTICALS INC | 7,750,000 (-3.1%) | $194,680 (+7.5%) | 3.5% | $34.58 | -32.2% | COM | 03753U106 |
| GERN | GERON CORP | 32,511,271 (-20.9%) | $42,915 (-23.8%) | 0.8% | $2.33 | -46.2% | COM | 374163103 |
| CMPS | COMPASS PATHWAYS PLC | 7,334,323 (-6.7%) | $50,607 (+12.4%) | 0.9% | $2.86 | — | SPONSORED ADS | 20451W101 |
| BBIO | BRIDGEBIO PHARMA INC | 810,142 (-32.5%) | $61,968 (-0.6%) | 1.1% | $35.75 | +83.6% | COM | 10806X102 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 1,900,738 (-5.0%) | $51,624 (-0.2%) | 0.9% | $26.06 | +1.1% | COM NEW | 15117B202 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | DYNAVAX TECHNOLOGIES CORP | 15,726,349 | $241,871 | 4.3% | $11.53 | — | COM NEW | 268158201 |
| TARS | TARSUS PHARMACEUTICALS INC | 3,004,034 | $245,970 | 4.4% | $48.96 | +52.5% | COM | 87650L103 |
| LBRX | LB PHARMACEUTICALS INC | 3,352,804 | $74,633 | 1.3% | $15.87 | +10.1% | COM SHS | 50180M108 |
| CNTX | CONTEXT THERAPEUTICS INC | 7,419,355 | $10,906 | 0.2% | $1.72 | -32.2% | COM | 21077P108 |
| ALGS | ALIGOS THERAPEUTICS INC | 444,110 | $4,139 | 0.1% | $16.71 | -43.5% | COM NEW | 01626L204 |
| CBIO | CRESCENT BIOPHARMA INC. | 453,686 | $5,381 | 0.1% | $21.15 | -39.8% | COM | G2545C104 |